Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis

Blood. 2017 Mar 30;129(13):1881-1883. doi: 10.1182/blood-2016-12-753210. Epub 2017 Feb 3.

Authors

Affiliations

¹ Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and.
² Department of Medicine, University of South Florida, Tampa, FL.

PMID: 28159734
DOI: 10.1182/blood-2016-12-753210

No abstract available

Publication types

Letter
Validation Study

MeSH terms

Female
GPI-Linked Proteins / blood
GPI-Linked Proteins / immunology
Humans
Leukemia, Myelomonocytic, Chronic* / blood
Leukemia, Myelomonocytic, Chronic* / immunology
Leukemia, Myelomonocytic, Chronic* / pathology
Lipopolysaccharide Receptors / blood
Lipopolysaccharide Receptors / immunology
Male
Monocytes* / immunology
Monocytes* / metabolism
Monocytes* / pathology
Monokines / blood
Monokines / immunology
Myelodysplastic Syndromes* / blood
Myelodysplastic Syndromes* / immunology
Myelodysplastic Syndromes* / pathology
Receptors, IgG / blood
Receptors, IgG / immunology

Substances

FCGR3B protein, human
GPI-Linked Proteins
Lipopolysaccharide Receptors
Monokines
Receptors, IgG